Status and prognostic value of immunological biomarkers of breast cancer.

导出 OA

翻译打印收藏纠错

第一作者： Chisa,Murazawa

第一单位： Department of Thoracic, Breast and Endocrine Surgery, Faculty of Medicine, Kagawa University, Kagawa 761-0793, Japan.

作者： Chisa,Murazawa ^[1] ; Nozomi,Hashimoto ^[1] ; Kana,Kuraishi ^[1] ; Mutsumi,Motoyama ^[2] ; Shin-Ichiro,Hashimoto ^[1] ; Mayumi,Ikeuchi ^[1] ; Shoko,Norimura ^[3] ; Toru,Matsunaga ^[2] ; Koji,Teramoto ^[4] ; Reiji,Haba ^[2] ; Noriko,Abe ^[1] ; Toshiki,Yajima ^[1] ; Keiichi,Kontani ^[1]

作者单位： Department of Thoracic, Breast and Endocrine Surgery, Faculty of Medicine, Kagawa University, Kagawa 761-0793, Japan. ^[1] Department of Diagnostic Pathology, Kagawa University Hospital, Kagawa 761-0793, Japan. ^[2] Department of Surgery, Takamatsu Red Cross Hospital, Takamatsu, Kagawa 760-0017, Japan. ^[3] Department of Medical Oncology, Shiga University of Medical Science, Otsu, Shiga 520-2191, Japan. ^[4]

关键词 CD8+ T lymphocytes MHC PD-L1 TILs biomarker breast cancer

DOI 10.3892/ol.2023.13750

PMID 36960188

发布时间 2023-03-25

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交